Breaking News Instant updates and real-time market news.

OCUL

Ocular Therapeutix

$3.36

-0.1 (-2.89%)

16:35
05/20/19
05/20
16:35
05/20/19
16:35

Ocular Therapeutix trading resumes

  • 11

    Jun

  • 10

    Nov

OCUL Ocular Therapeutix
$3.36

-0.1 (-2.89%)

12/04/18
HCWC
12/04/18
NO CHANGE
Target $12
HCWC
Buy
Ocular Therapeutix price target raised to $12 from $10 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Ocular Therapeutix to $12 after the FDA approved Dextenza for intracanalicular use for the treatment of ocular pain following ophthalmic surgery. The analyst believes the news should bolster confidence in the company among investors. The approval not only validates Ocular's hydrogel drug delivery platform, but endorses the incumbent management team's execution and accountability, Selvaraju tells investors in a research note. He reiterates a Buy rating on the name.
01/04/19
PIPR
01/04/19
NO CHANGE
Target $14
PIPR
Overweight
Piper sees 'significant share appreciation' potential for Ocular Therapeutix
Ocular Therapeutix expects top-line data from OTX-TP's first Phase III glaucoma study in the first half of 2019, Piper Jaffray analyst Joseph Catanzaro tells investors in a research note. The analyst believes investors have discounted this program based on mixed Phase I/II data that utilized different formulations and study designs. However, he thinks the Phase III design gives OTX-TP the best chance at demonstrating clinical efficacy in this setting. A successful outcome will be statistically significant IOP-reductions over placebo at all time points and importantly, at least a 5 mm Hg reduction in IOP from baseline at 6 of the 9 time points, Catanzaro contends, citing his review of literature and a survey of ophthalmologists. He believes such an outcome would represent "another successful application of the hydrogel platform and drive significant share appreciation." The analyst has an Overweight rating on Ocular Therapeutix with a $14 price target.
03/08/19
PIPR
03/08/19
NO CHANGE
Target $14
PIPR
Overweight
Ocular undervalued ahead of glaucoma data, says Piper Jaffray
Ahead of Dextenza's planned mid-2019 U.S. launch for post-cataract pain, Ocular Therapeutix is expected to report data from both OTX-TP and OTX-TIC in glaucoma are expected in first half of 2019, Piper Jaffray analyst Joseph Catanzaro tells investors in a research note. Now funded into 2020, Ocular shares remain undervalued for its suite of hydrogel-based products for both the front and back of the eye, Catanzaro contends. He maintains an Overweight rating on the shares with a $14 price target.
03/28/19
PIPR
03/28/19
NO CHANGE
Target $14
PIPR
Overweight
Ocular Therapeutix's Dextenza may provide substantial upside, says Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro kept his Overweight rating and $14 price target on Ocular Therapeutix after its R&D day highlighting the company's preparations for a mid-2019 Dextenza launch as well as the overall breadth of the hydrogel platform. The analyst believes that while Dextenza gives Ocular Therapeutix a "nice foundation", the company also has "opportunities to expand in post-ophthalmic surgery, glaucoma, dry eye, retinal disease, as well as sinusitis,osteoarthritis and post-op incisional pain." Catanzaro speculates that Ocular Therapeutix could file up to 4 Investigational New Drug submissions per year.

TODAY'S FREE FLY STORIES

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

, AGN

Allergan

$129.65

-1.32 (-1.01%)

09:31
06/25/19
06/25
09:31
06/25/19
09:31
Hot Stocks
AbbVie says looked at Allergan deal for over a year »

Says: Highly unlikely to…

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

AGN

Allergan

$129.65

-1.32 (-1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

MHK

Mohawk

$146.01

0.025 (0.02%)

09:31
06/25/19
06/25
09:31
06/25/19
09:31
Recommendations
Mohawk analyst commentary  »

Mohawk challenges persist…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
06/25/19
06/25
09:30
06/25/19
09:30
General news
Treasury Action: Treasuries are holding modest gains »

Treasury Action:…

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
HSBC to hold a conference »

Transport, Infrastructure…

09:25
06/25/19
06/25
09:25
06/25/19
09:25
General news
U.S. April FHFA home price index was up 0.4% to 274.7 »

U.S. April FHFA home…

BJRI

BJ's Restaurants

$43.61

0.81 (1.89%)

, CAKE

Cheesecake Factory

$43.39

-0.79 (-1.79%)

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
Wedbush restaurants analyst to hold an analyst/industry conference call »

Restaurants Analyst…

BJRI

BJ's Restaurants

$43.61

0.81 (1.89%)

CAKE

Cheesecake Factory

$43.39

-0.79 (-1.79%)

CMG

Chipotle

$724.14

-3.035 (-0.42%)

DIN

Dine Brands

$95.49

0.235 (0.25%)

DRI

Darden

$122.14

0.92 (0.76%)

JACK

Jack in the Box

$82.83

-2.33 (-2.74%)

SBUX

Starbucks

$83.65

-0.16 (-0.19%)

TXRH

Texas Roadhouse

$52.25

-0.1 (-0.19%)

WEN

Wendy's

$19.15

-0.22 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 08

    Aug

  • 14

    Aug

  • 21

    Aug

  • 22

    Aug

  • 27

    Aug

  • 28

    Aug

  • 13

    Nov

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
Senate Agriculture, Nutrition & Forestry Committee to hold a hearing »

The Committee holds a…

MOR

MorphoSys

$26.23

1.16 (4.63%)

09:25
06/25/19
06/25
09:25
06/25/19
09:25
Conference/Events
MorphoSys to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 07

    Aug

09:21
06/25/19
06/25
09:21
06/25/19
09:21
Conference/Events
Goldman Sachs to hold a conference »

15th Annual European…

CBMG

Cellular Biomedicine

$15.01

(0.00%)

09:21
06/25/19
06/25
09:21
06/25/19
09:21
Initiation
Cellular Biomedicine initiated  »

Cantor Fitzgerald bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LH

LabCorp

$169.36

-1.48 (-0.87%)

, DGX

Quest Diagnostics

$100.87

-0.43 (-0.42%)

09:21
06/25/19
06/25
09:21
06/25/19
09:21
Recommendations
LabCorp, Quest Diagnostics analyst commentary  »

Deutsche says…

LH

LabCorp

$169.36

-1.48 (-0.87%)

DGX

Quest Diagnostics

$100.87

-0.43 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

09:20
06/25/19
06/25
09:20
06/25/19
09:20
General news
U.S. Case Shiller home price index rose 0.8% in April to 215.68 for the 20-City index »

U.S. Case Shiller home…

PRPO

Precipio

$2.93

-0.11 (-3.62%)

09:19
06/25/19
06/25
09:19
06/25/19
09:19
Hot Stocks
Precipio initiates second development project with H3 Biomedicine for gene panel »

Precipio announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
06/25/19
06/25
09:18
06/25/19
09:18
Options
Overnight activity included 195 trades in SPX and 9 trades in VIX »

195 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$45.69

-3.67 (-7.44%)

, CELG

Celgene

$93.48

-5.44 (-5.50%)

09:12
06/25/19
06/25
09:12
06/25/19
09:12
Recommendations
Bristol-Myers, Celgene analyst commentary  »

Bristol-Myers sentiment…

BMY

Bristol-Myers

$45.69

-3.67 (-7.44%)

CELG

Celgene

$93.48

-5.44 (-5.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

MSFT

Microsoft

$137.80

0.86 (0.63%)

09:11
06/25/19
06/25
09:11
06/25/19
09:11
Conference/Events
Jefferies software analyst to hold an analyst/industry conference call »

Software Analyst DiFucci…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 06

    Aug

PYDS

Payment Data Systems

$3.39

(0.00%)

09:10
06/25/19
06/25
09:10
06/25/19
09:10
Hot Stocks
Payment Data Systems to change name to Usio »

Payment Data Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 22

    Aug

09:10
06/25/19
06/25
09:10
06/25/19
09:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD headed…

TELNY

Telenor

$0.00

(0.00%)

09:08
06/25/19
06/25
09:08
06/25/19
09:08
Downgrade
Telenor rating change  »

Telenor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

AGN

Allergan

$129.65

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41

-0.37 (-0.47%)

09:07
06/25/19
06/25
09:07
06/25/19
09:07
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Allergan (AGN),…

AGN

Allergan

$129.65

-1.32 (-1.01%)

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

PYX

Pyxus

$13.42

-1.1 (-7.58%)

ARQL

ArQule

$10.00

-0.48 (-4.58%)

LEN

Lennar

$51.41

0.09 (0.18%)

BHF

Brighthouse Financial

$38.10

-0.01 (-0.03%)

PVTL

Pivotal Software

$11.35

-0.15 (-1.30%)

SBH

Sally Beauty

$12.30

-2.49 (-16.84%)

ALDX

Aldeyra

$7.08

-0.29 (-3.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

  • 11

    Jul

  • 16

    Sep

  • 25

    Jun

09:06
06/25/19
06/25
09:06
06/25/19
09:06
General news
FHFA House Price Index M/M change data reported »

April FHFA House Price…

AETI

American Electric Tech.

$0.69

-0.0099 (-1.41%)

09:05
06/25/19
06/25
09:05
06/25/19
09:05
Hot Stocks
American Electric Tech. receives $725,000 distribution from Bomay joint venture »

American Electric Tech.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

09:05
06/25/19
06/25
09:05
06/25/19
09:05
General news
NY Fed's Williams didn't discuss monetary policy or the economy »

NY Fed's Williams…

09:04
06/25/19
06/25
09:04
06/25/19
09:04
General news
S&P/Corelogic Case-Shiller Home Price Index data reported. »

April S&P/Corelogic…

ZTS

Zoetis

$113.46

0.6 (0.53%)

09:03
06/25/19
06/25
09:03
06/25/19
09:03
Recommendations
Zoetis analyst commentary  »

Zoetis price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.